Moderna ramps up EU COVID jab capacity via Lonza dealCapacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, Share XModerna ramps up EU COVID jab capacity via Lonza dealhttps://pharmaphorum.com/news/moderna-ramps-up-eu-covid-jab-capacity-via-lonza-deal/
EU starts rolling review of Sinovac’s COVID-19 vaccineEurope’s regulator has begun a rolling review of Sinovac’s COVID-19 vaccine, known as Vero Cell. The vaccine is Share XEU starts rolling review of Sinovac’s COVID-19 vaccinehttps://pharmaphorum.com/news/eu-regulator-begins-review-of-sinovacs-covid-19-vaccine/
China approves Sinovac’s coronavirus vaccineChina’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the Share XChina approves Sinovac’s coronavirus vaccinehttps://pharmaphorum.com/news/china-approves-sinovacs-coronavirus-vaccine/
Sinovac raises $515m to boost production of potential COVID-19 vaccineChina’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its Share XSinovac raises $515m to boost production of potential COVID-19 vaccinehttps://pharmaphorum.com/news/sinovac-raises-515m-to-boost-production-of-potential-covid-19-vaccine/
